Robert Merrell, MD
NPI 1699765586ActiveIndividual· Internal Medicine, Nephrology· Boulder City, NV
Internal Medicine, Nephrology (MD) in Boulder City, Nevada, licensed in NV, with an NPI issued in October 2005. Their prescriptions cost Medicare Part D more than their services did: $161,954 for 317 claims, against $8,308 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 5 companies reporting payments in 2024, $120.40 in all, mostly food and beverage.
Overview
| NPI | 1699765586 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Oct 24, 2005 |
| Last updated in NPPES | Mar 3, 2025 |
| Certified by provider | Mar 3, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Nephrology Primary | 207RN0300X | 5932 | NV |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Nephrology (NV) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 49 |
|---|---|
| Services billed | 148 across 10 procedure codes |
| Paid by Medicare | $8,308 |
Part D prescriptions in 2024
| Prescriptions (claims) | 317 · 739 30-day fills |
|---|---|
| Patients | 47 |
| Total drug cost | $161,954 |
| Generic share | 70% of claims |
Industry payments (Open Payments)
- 2024$120.40 · 6 payments from 5 companies
Top paying companies in 2024
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $43.18 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.64 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.87 | 1 |
| Calliditas Therapeutics US Inc. | $19.40 | 1 |
| Ardelyx, Inc. | $14.31 | 1 |
What the 2024 payments were for
- Food and Beverage$120.40 · 6 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records